U.S. Niche Equities and Leveraged ETFs See Surprising Mid-2026 ActivityGlobal Report·Sep 23 at 10:12 AMTDAX+0.91%SMNR-21.05%
M&A and Fundamental Divergence Send Clear Signals: Corporate Strategy Resets Behind 10 Niche US EquitiesGlobal Report·Sep 16 at 10:12 AMCRMU-5.12%MTBLY0.00%
The Great Pivot: How a Mismatched Cohort of SPACs, Biotechs, and Legacy Giants Are Navigating the New Economic RealityGlobal Report·Aug 18 at 10:12 AMNUVB-7.55%DGXX-3.27%
Semnur signs term sheet for $100 million unregistered share sale to iHolding Group at $10 per sharePUBT·Jul 7 at 10:03 AMSMNR-21.05%
Semnur Shareholders Approve Director, Auditor and Equity PlansTip Ranks·Jun 25 at 09:31 PMSMNR-21.05%
Semnur Pharmaceuticals Announces CEO Transition and Leadership ChangesTip Ranks·Mar 17 at 08:29 PMIBB-0.33%VHT+0.06%
Semnur appoints Henry Ji as CEO & President; Jaisim Shah retiresTradingView·Mar 17 at 08:23 PMSMNRW0.00%BIB-0.61%
Semnur Pharmaceuticals, Inc. | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 12, 2025 at 09:17 PMSMNR-21.05%
DENALI CAPITAL ACQUISITION CORP | 10-Q: FY2025 Q2 EPS: USD -0.15Earnings Watch·Aug 15, 2025 at 11:51 AMDNQAF0.00%SMNR-21.05%
Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination | DECA Stock NewsStockTitan·Apr 14, 2025 at 08:35 PMDECAU0.00%DECA0.00%
Denali Capital Acquisition Corp. Announces Adjournment of Extraordinary General Meeting of Shareholders to April 11, 2025 at 10:00 AM ET.GlobeNewswire·Apr 10, 2025 at 08:00 PMDECAU0.00%DECA0.00%
